Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-02

Clinical Trial Update: Dark Chocolate, Coconut Water, and Ibuprofen in Managing Primary Dysmenorrhea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dark chocolate, coconut water, and ibuprofen for managing primary dysmenorrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coconut water
  • Dark chocolate
  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Dysmenorrhea Primary, Menstrual Pain | Phase 2 | Status: COMPLETED